Ginkgo biloba extract ameliorates skin fibrosis in a bleomycin-induced mouse model of systemic sclerosis

References

• Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, et al. 2012. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun. 3:735. doi:10.1038/ncomms1734.
   PubMed Web of Science ®Google Scholar
• Al-Attar AM. 2012. Attenuating effect of ginkgo biloba leaves extract on liver fibrosis induced by thioacetamide in mice. J Biomed Biotechnol. 2012:761450. doi:10.1155/2012/761450.
   PubMedGoogle Scholar
• Au K, Singh MK, Bodukam V, Bae S, Maranian P, Ogawa R, Spiegel B, McMahon M, Hahn B, Khanna D. 2011. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum. 63(7):2078–2090. doi:10.1002/art.30380.
   PubMed Web of Science ®Google Scholar
• Ayers NB, Sun C-M, Chen S-Y. 2018. Transforming growth factor-β signaling in systemic sclerosis. J Biomed Biotechnol. 32(1):3–12. doi:10.7555/JBR.31.20170034.
   Google Scholar
• Brown M, O’Reilly S. 2019. The immunopathogenesis of fibrosis in systemic sclerosis. Clin Exp Immunol. 195(3):310–321. doi:10.1111/cei.13238.
   PubMed Web of Science ®Google Scholar
• Cannarile F, Valentini V, Mirabelli G, Alunno A, Terenzi R, Luccioli F, Gerli R, Bartoloni E. 2015. Cardiovascular disease in systemic sclerosis. Ann Transl Med. 3(1):8. doi:10.3978/j.issn.2305-5839.2014.12.12.
   PubMedGoogle Scholar
• Clark JG, Starcher BC, Uitto J. 1980. Bleomycin-induced synthesis of type I procollagen by human lung and skin fibroblasts in culture. Biochimica et Biophysica Acta (BBA) - General Subjects. 631(2):359–370. doi:10.1016/0304-4165(80)90309-8.
   PubMedGoogle Scholar
• Datta SR, Brunet A, Greenberg ME. 1999. Cellular survival: a play in three akts. Genes Dev. 13(22):2905–2927. doi:10.1101/gad.13.22.2905.
   PubMed Web of Science ®Google Scholar
• Ebmeier S, Horsley V. 2015. Origin of fibrosing cells in systemic sclerosis. Curr Opin Rheumatol. 27(6):555–562. doi:10.1097/BOR.0000000000000217.
   PubMed Web of Science ®Google Scholar
• Eom J, Choi J, Suh S-S, Seo JB. 2022. Slc3a2 and SLC7A2 mediate the exogenous putrescine-induced adipocyte differentiation. Mol Cells. 45(12):963–975. doi:10.14348/molcells.2022.0123.
   PubMed Web of Science ®Google Scholar
• Finnson KW, Almadani Y, Philip A. 2020. Non-canonical (non-SMAD2/3) TGF-β signaling in fibrosis: mechanisms and targets. Semin Cell Dev Biol. 101:115–122. doi:10.1016/j.semcdb.2019.11.013.
   PubMed Web of Science ®Google Scholar
• Gabrielli A, Avvedimento EV, Krieg T. 2009. Scleroderma. N Engl J Med. 360(19):1989–2003. doi:10.1056/NEJMra0806188.
   PubMed Web of Science ®Google Scholar
• Ihn H. 2002. Pathogenesis of fibrosis: role of TGF-β and CTGF. Curr Opin Rheumatol. 14(6):681–685. doi:10.1097/00002281-200211000-00009.
   PubMed Web of Science ®Google Scholar
• Iraz M, Erdogan H, Kotuk M, Yağmurca M, Kilic T, Ermis H, Fadillioğlu E, Yildirim Z. 2006. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacol Res. 53(3):310–316. doi:10.1016/j.phrs.2005.12.009.
   PubMed Web of Science ®Google Scholar
• Ji H-J, Zhou X-H, Wu H-Y, Liu H-X, Zhang G-Z. 2023. A bibliometric and thematic analysis of the trends in the research on ginkgo biloba extract from 1985 to 2022. Heliyon. 9(11):e21214. doi:10.1016/j.heliyon.2023.e21214.
   PubMed Web of Science ®Google Scholar
• Jimenez SA, Derk CT. 2004. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med. 140(1):37–50. doi:10.7326/0003-4819-140-1-200401060-00010.
   PubMed Web of Science ®Google Scholar
• Jun J-B, Kuechle M, Harlan JM, Elkon KB. 2003. Fibroblast and endothelial apoptosis in systemic sclerosis. Curr Opin Rheumatol. 15(6):756–760. doi:10.1097/00002281-200311000-00012.
   PubMed Web of Science ®Google Scholar
• Jun J-B, Kuechle M, Min J, Shim SC, Kim G, Montenegro V, Korn JH, Elkon KB. 2005. Scleroderma fibroblasts demonstrate enhanced activation of Akt (protein kinase B) in situ. J Invest Dermatol. 124(2):298–303. doi:10.1111/j.0022-202X.2004.23559.x.
   PubMed Web of Science ®Google Scholar
• Ko J, Noviani M, Chellamuthu VR, Albani S, Low AHL. 2023. The pathogenesis of systemic sclerosis: The origin of fibrosis and interlink with vasculopathy and autoimmunity. Int J Mol Sci. 24(18):14287. doi:10.3390/ijms241814287.
   PubMed Web of Science ®Google Scholar
• Korman B. 2019. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis. Transl Res. 209:77–89. doi:10.1016/j.trsl.2019.02.010.
   PubMed Web of Science ®Google Scholar
• Lafyatis R. 2014. Transforming growth factor β—at the centre of systemic sclerosis. Nat Rev Rheumatol. 10(12):706–719. doi:10.1038/nrrheum.2014.137.
   PubMed Web of Science ®Google Scholar
• Lee H, Park SJ, Hong S, Lim S-W, Kim S. 2022. Deletion of IP6K1 in mice accelerates tumor growth by dysregulating the tumor-immune microenvironment. Animal Cell Syst (Seoul). 26(1):19–27. doi:10.1080/19768354.2022.2029560.
   PubMed Web of Science ®Google Scholar
• Li Y-J, Shi J-R, Li S-C, Wang L-M, Dhar R, Li N, Cao X-W, Li Z-G, Tang H-F. 2023. Phosphodiesterase type 10A inhibitor attenuates lung fibrosis by targeting myofibroblast activation. iScience. 26(5):106586. doi:10.1016/j.isci.2023.106586.
   PubMed Web of Science ®Google Scholar
• Liang M, Lv J, Chu H, Wang J, Chen X, Zhu X, Xue Y, Guan M, Zou H. 2014. Vertical inhibition of PI3K/Akt/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity. J Dermatol Sci. 76(2):104–111. doi:10.1016/j.jdermsci.2014.08.002.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang Y, Zhang J, Wang S. 2021. Advances in the chemical constituents and chemical analysis of ginkgo biloba leaf, extract, and phytopharmaceuticals. J Pharm Biomed Anal. 193:113704. doi:10.1016/j.jpba.2020.113704.
   PubMed Web of Science ®Google Scholar
• Lu Q, Zuo W-Z, Ji X-J, Zhou Y-X, Liu Y-Q, Yao X-Q, Zhou X-Y, Liu Y-W, Zhang F, Yin X-X. 2015. Ethanolic ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy. Phytomedicine. 22(12):1071–1078. doi:10.1016/j.phymed.2015.08.010.
   PubMed Web of Science ®Google Scholar
• Marangoni RG, Korman BD, Wei J, Wood TA, Graham LV, Whitfield ML, Scherer PE, Tourtellotte WG, Varga J. 2015. Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors. Arthrit Rheumatol.. 67(4):1062–1073. doi:10.1002/art.38990.
   PubMed Web of Science ®Google Scholar
• Moon KW, Lee S-S, Lee YJ, Jun J-B, Yoo S-J, Ju JH, Chang SH, Choi IA, Kang TY, Lee EB, Lee S-G. 2018. Clinical and laboratory characteristics and mortality in Korean patients with systemic sclerosis: A nationwide multicenter retrospective cohort study. J Rheumatol. 45(9):1281–1288. doi:10.3899/jrheum.171443.
   PubMed Web of Science ®Google Scholar
• Ntelis K, Bogdanos D, Dimitroulas T, Sakkas L, Daoussis D. 2019. Platelets in systemic sclerosis: the missing link connecting vasculopathy, autoimmunity, and fibrosis? Curr Rheumatol Rep. 21(5):15. doi:10.1007/s11926-019-0815-z.
   PubMed Web of Science ®Google Scholar
• Papadimitriou T-I, van Caam A, van der Kraan PM, Thurlings RM. 2022. Therapeutic options for systemic sclerosis: current and future perspectives in tackling immune-mediated fibrosis. Biomedicines. 10(2):316. doi:10.3390/biomedicines10020316.
   PubMed Web of Science ®Google Scholar
• Park E-K, Park J-H, Kweon S-M, Kim G-T, Lee S-G. 2017. Vitamin D deficiency is associated with digital ulcer but not with atherosclerosis or arterial stiffness in patients with systemic sclerosis: a pilot study. Clin Rheumatol. 36(6):1325–1333. doi:10.1007/s10067-017-3622-9.
   PubMed Web of Science ®Google Scholar
• Piera-Velazquez S, Li Z, Jimenez SA. 2011. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol. 179(3):1074–1080. doi:10.1016/j.ajpath.2011.06.001.
   PubMed Web of Science ®Google Scholar
• Roh JS, Jeong H, Lee B, Song BW, Han SJ, Sohn DH, Lee S-G. 2021. Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis. Animal Cell Syst (Seoul). 25(6):387–395. doi:10.1080/19768354.2021.1995486.
   PubMed Web of Science ®Google Scholar
• Tian J, Liu Y, Chen K. 2017. Ginkgo biloba extract in vascular protection: molecular mechanisms and clinical applications. Curr Vasc Pharmacol. 15(6):532–548. doi:10.2174/1570161115666170713095545.
   PubMed Web of Science ®Google Scholar
• Tourkina E, Bonner M, Oates J, Hofbauer A, Richard M, Znoyko S, Visconti RP, Zhang J, Hatfield CM, Silver RM, Hoffman S. 2011. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair. 4(1):15. doi:10.1186/1755-1536-4-15.
   PubMedGoogle Scholar
• Varga J, Marangoni RG. 2017. Dermal white adipose tissue implicated in SSc pathogenesis. Nat Rev Rheumatol. 13(2):71–72. doi:10.1038/nrrheum.2016.223.
   PubMed Web of Science ®Google Scholar
• Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, Brenner M, Guo G, Zhang W, Oliver N, et al. 2011. Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease. Fibrogenesis Tissue Repair. 4(1):4. doi:10.1186/1755-1536-4-4.
   PubMedGoogle Scholar
• Wang Y, Wang R, Wang Y, Peng R, Wu Y, Yuan Y. 2015. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling. Drug Des Devel Ther. 9:6303–6317. doi:10.2147/DDDT.S93732.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Eckes B, Krieg T. 2000. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts. Arch Dermatol Res. 292(11):556–561. doi:10.1007/s004030000180.
   PubMed Web of Science ®Google Scholar
• Yang L, Serada S, Fujimoto M, Terao M, Kotobuki Y, Kitaba S, Matsui S, Kudo A, Naka T, Murota H, Katayama I. 2012. Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. PLoS One. 7(7):e41994. doi:10.1371/journal.pone.0041994.
   PubMed Web of Science ®Google Scholar
• Yun E, Kwon BS, Kim J, Lee A. 2023. Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition. Animal Cell Syst (Seoul). 27(1):159–170. doi:10.1080/19768354.2023.2244549.
   PubMed Web of Science ®Google Scholar
• Zhang X-L, Xing R-G, Chen L, Liu C-R, Miao Z-G. 2016. PI3K/Akt signaling is involved in the pathogenesis of bleomycin-induced pulmonary fibrosis via regulation of epithelial-mesenchymal transition. Mol Med Rep. 14(6):5699–5706. doi:10.3892/mmr.2016.5960.
   PubMed Web of Science ®Google Scholar